CD4-positive T-helper cell responses to the PASD1 protein in patients with diffuse large B-cell lymphoma

BACKGROUND: Vaccine development targeting the novel immunogenic Per ARNT Sim Domain containing 1 (PASD1) cancer testis antigen represents an attractive therapeutic approach for the significant number of patients with diffuse large B-cell lymphoma who are refractory to conventional treatment. Since C...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Ait-Tahar, Kamel, Liggins, Amanda P., Collins, Graham P., Campbell, Andrew, Barnardo, Martin, Cabes, Maite, Lawrie, Charles H., Moir, Donald, Hatton, Chris, Banham, Alison H., Pulford, Karen
Format: Artigo
Jezik:Inglês
Izdano: Ferrata Storti Foundation 2011
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3012768/
https://ncbi.nlm.nih.gov/pubmed/20851862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2010.028241
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items